AtomVie Partners with Jubilant Radiopharma for Radiopharmaceutical Logistics

HAMILTON, ON, Oct. 15, 2026 /CourierPR/ -- AtomVie Global Radiopharma, a leading global contract development and manufacturing organization (CDMO) dedicated to advancing the development and commercialization of radiopharmaceuticals, has entered into a strategic partnership with Jubilant Radiopharma to enhance its logistics, regulatory, and last-mile distribution services. This collaboration aims to streamline the delivery of radiopharmaceuticals to clinical sites while maintaining the highest standards of quality, safety, and regulatory compliance.

AtomVie, operating from its state-of-the-art, 72,300 sq. ft. facility in Hamilton, Ontario, has been at the forefront of radiopharmaceutical development. The partnership with Jubilant Radiopharma, a trusted provider of radiopharmaceutical products and services with one of the largest pharmacy networks in the United States, will significantly bolster AtomVie's service offerings. Jubilant Radiopharma, with more than 70 years of experience serving the nuclear medicine community, will support the receipt, handling, regulatory compliance, and last-mile distribution of AtomVie-manufactured radiopharmaceuticals across its U.S. pharmacy network.

The partnership further strengthens AtomVie's integrated service offering. By leveraging Jubilant Radiopharma's established distribution infrastructure and specialized capabilities spanning clinical trials, therapeutic dispensing, and commercialization, AtomVie and its clients will benefit from enhanced access to clinical trial sites and greater operational flexibility as development programs advance.

AtomVie Global Radiopharma Inc. is a leading global CDMO dedicated to advancing the development and commercialization of radiopharmaceuticals. AtomVie offers integrated solutions spanning process development, GMP manufacturing, quality control, regulatory support, and global distribution services for clinical and commercial programs. Operating from its state-of-the-art, 72,300 sq. ft. facility in Hamilton, Ontario, AtomVie supports pharmaceutical and biotechnology companies developing innovative radiotherapeutics and diagnostics worldwide.

Jubilant Radiopharma, a business segment of Jubilant Pharmova Limited, is a leading radiopharmaceutical company focused on the development, manufacturing, distribution, and commercialization of radiopharmaceutical products and services. Through one of the largest radiopharmacy networks in the United States, Jubilant Radiopharmacies supports diagnostic and therapeutic radiopharmaceutical programs with clinical trial logistics, regulatory support, therapeutic dispensing, site activation, and nationwide distribution capabilities.